Surge in demand for tissue engineering, and cell and gene therapy for various indications such as oncology, musculoskeletal disorders, orthopedics, neurology, cardiology, and others is expected to drive the advanced therapy medicinal products market demand.
ATMPs include cell, gene, tissue-engineered, and somatic-cell therapy medicines. They treat the root cause of diseases and disorders by augmenting, repairing, replacing, or regenerating organs, tissues, cells, genes, and metabolic processes in the body.
The cell therapy market has expanded due to rise in investment to fund clinical trials. Increase in cases of Alzheimer's disease and prevalence of neurodegenerative diseases around the world, rise in demand for advanced gene therapies, and surge in geriatric population and genetic disorders are further fueling the advanced therapy medicinal products market size.
Emergence of advanced therapy medicinal products (ATMPs) has transformed the pharmaceutical industry and disease treatment landscape. It has opened new routes for the treatment of incurable diseases and several cancer types. The success of products such as Kymriah and Zolgensma, is a key factor driving advanced therapy medicinal products market progress.
Rise in expansion of facilities to advance tissue engineering is expected to fuel the overall advanced therapy medicinal products market during the forecast period. In October 2023, a new research announcement was made to leverage the unique environment of the International Space Station (ISS) to advance tissue engineering and bio-manufacturing.
The ISS National Laboratory is soliciting concepts for applied research and technology development for regenerative medicine applications seeking to demonstrate space-based manufacturing and production activities for terrestrial applications.
Through this research announcement, multiple projects will be awarded funding to support project costs, hardware and integration costs, and flight allocation to the orbiting laboratory.
| Attribute | Detail |
|---|---|
| Drivers |
|
According to an article published in Nature Reviews Drug Discovery in June 2021, 2,073 cell therapies in the global pipeline were marked as active, an increase of 572 over the update in 2020 as of April 16, 2021.
Various cell and gene therapies are under approval phases. For instance, in March 2024, Atidarsagene autotemcel, a gene-edited cell therapy developed by Orchard Therapeutics, designed to restore arylsulfatase A (ARSA) enzyme activity in children with presymptomatic (PS) late infantile (LI), PS early juvenile (EJ), or early symptomatic (ES) early juvenile (EJ) metachromatic leukodystrophy (MLD) was approved by the U.S. FDA in the United States, following its approval in the European Union, UK, Iceland, Switzerland, Liechtenstein, and Norway under the name Libmeldly.
Similarly, in February, 2024, jCyte, Inc., a pioneering biotechnology company dedicated to preserving and restoring vision in patients with retinitis pigmentosa (RP) and other degenerative retinal disorders, announced the successful outcome of its pre- phase 3 Type B meeting with the U.S. Food and Drug Administration (FDA) held on January 16, 2024. The company is gearing to commence its pivotal US trial in the second half of 2024.
On February 1, 2024, U.S. FDA granted a fast track designation to the T-cell therapy BST02 for the treatment of patients with all forms of liver cancer, including hepatocellular carcinoma (HCC) and cholangiocarcinoma.
BST02 is a novel adoptive immune cell therapy that depends on the expansion of tumor-infiltrating lymphocytes (TILs) derived from a patient’s cells. Notably, BST02 does not require high doses of interleukin-2 and is cryopreserved, overcoming distance constraints with traditional TIL therapies.
Thus, surge in number of clinical trials under pipeline is likely to drive the advanced therapy medicinal products market revenue in the near future
Recent ATMP approvals have prompted an unprecedented expansion of the market. Pharmaceutical companies that produce conventional drugs are vying for a competitive edge because they see ATMPs as a potential income stream for future healthcare systems.
Currently, the market is highly active, and companies are investing significantly in clinical trials of ATMPs post the success of approved products.
Companies are adopting various operation models to accelerate the product manufacturing process. Some have undertaken in-house production of therapies, while many players prefer third-party service providers, including contract manufacturing organizations.
On the other hand, several companies have marked their presence in the market by acquiring small and emerging CAR T-cell therapy developers. After Luxturna, Yescarta, and Kymriah's clearance, the market saw several acquisitions by organizations looking to enter or expand their current businesses in this industry.
Some notable and recent examples include the purchases of Kite Pharma by Gilead Life Science, AveXis by Novartis, and Juno Therapeutics by Celgene. These factors boost advanced therapy medicinal products market statistics.
The rise in competition among key players to gain substantial market share in the space is anticipated to propel research and development investment flow. For instance, in October 2021, Leucid Bio announced an investment of US$ 15.26 million (1 GBP=1.33 USD) for the development of the next generation of innovative CAR-T therapies.
Similarly, in June 2021, Blackstone Life Sciences collaborated with Cellex Cell Professionals and Intellia Therapeutics to launch a new CAR-T cell therapy company. These developments are expected to play a vital role in defining market growth.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest advanced therapy medicinal products market analysis, North America dominates the landscape. Advanced healthcare expenditure, including well established clinics and hospitals equipped with modern diagnostic and treatment options are driving market dynamics in the region.
The market in North America is dominated by the gene therapy and tissue engineering segment. However, the tissue engineering segment holds a slightly higher market share in North America due to the growth in geriatric population and surge in incidence of chronic diseases.
Advanced technology for diagnosis and treatment of chronic disorders, availability of private and government funding, and high healthcare spending are some of the factors responsible for North America’s significant advanced therapy medicinal products market share .
The market is fragmented with the presence of a large number of players. Companies are engaging in partnerships and collaborations to gain a strong foothold in the market.
Spark Therapeutics, Inc., Bluebird Bio, Inc., Novartis AG, UniQure N.V., MEDIPOST, Vericel Corporation, PHARMICELL Co., Ltd, and Organogenesis Inc., are the prominent advanced therapy medicinal products market manufacturers.
Key players have been profiled in the advanced therapy medicinal products market research report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.
| Attribute | Detail |
|---|---|
| Size in 2023 | US$ 45.8 Bn |
| Forecast Value in 2034 | More than US$ 245.1 Bn |
| CAGR | 16.6% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 45.8 Bn in 2023
It is projected to reach more than US$ 245.1 Bn by the end of 2034
The CAGR is anticipated to be 16.6% from 2024 to 2034
North America is expected to account for the largest share from 2024 to 2034
Spark Therapeutics, Inc., Bluebird Bio, Inc., Novartis AG, UniQure N.V., MEDIPOST, Vericel Corporation, PHARMICELL Co., Ltd, and Organogenesis Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Advanced Therapy Medicinal Products Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Advanced Therapy Medicinal Products Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario
5.2. Disease Prevalence & Incidence Rate Globally With Key Countries
5.3. Reimbursement Scenario
5.4. Mergers, Acquisition, Partnership, and Collaboration Scenario
5.5. COVID-19 Pandemic Impact Analysis
6. Global Advanced Therapy Medicinal Products Market Analysis and Forecasts, By Therapy Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Therapy Type, 2020-2034
6.3.1. Cell Therapy
6.3.2. Gene Therapy
6.3.3. Tissue Engineering
6.4. Market Attractiveness By Therapy Type
7. Global Advanced Therapy Medicinal Products Market Analysis and Forecasts, By Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Indication, 2020-2034
7.3.1. Oncology
7.3.2. Neurology
7.3.3. Cardiology
7.3.4. Dermatology
7.3.5. Infectious Diseases
7.3.6. Musculoskeletal Disorders
7.3.7. Orthopedics
7.3.8. Others (Genetic Disorders, etc.)
7.4. Market Attractiveness By Indication
8. Global Advanced Therapy Medicinal Products Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Others
8.4. Market Attractiveness By End-user
9. Global Advanced Therapy Medicinal Products Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Advanced Therapy Medicinal Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Therapy Type, 2020-2034
10.2.1. Cell Therapy
10.2.2. Gene Therapy
10.2.3. Tissue Engineering
10.3. Market Value Forecast By Indication, 2020-2034
10.3.1. Oncology
10.3.2. Neurology
10.3.3. Cardiology
10.3.4. Dermatology
10.3.5. Infectious Diseases
10.3.6. Musculoskeletal Disorders
10.3.7. Orthopedics
10.3.8. Others (Genetic Disorders, etc.)
10.4. Market Value Forecast By End-user, 2020-2034
10.4.1. Hospitals
10.4.2. Specialty Clinics
10.4.3. Others
10.5. Market Value Forecast By Country, 2020-2034
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Therapy Type
10.6.2. By Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Advanced Therapy Medicinal Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Therapy Type, 2020-2034
11.2.1. Cell Therapy
11.2.2. Gene Therapy
11.2.3. Tissue Engineering
11.3. Market Value Forecast By Indication, 2020-2034
11.3.1. Oncology
11.3.2. Neurology
11.3.3. Cardiology
11.3.4. Dermatology
11.3.5. Infectious Diseases
11.3.6. Musculoskeletal Disorders
11.3.7. Orthopedics
11.3.8. Others (Genetic Disorders, etc.)
11.4. Market Value Forecast By End-user, 2020-2034
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Others
11.5. Market Value Forecast By Country/Sub-region, 2020-2034
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Therapy Type
11.6.2. By Indication
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Advanced Therapy Medicinal Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Therapy Type, 2020-2034
12.2.1. Cell Therapy
12.2.2. Gene Therapy
12.2.3. Tissue Engineering
12.3. Market Value Forecast By Indication, 2020-2034
12.3.1. Oncology
12.3.2. Neurology
12.3.3. Cardiology
12.3.4. Dermatology
12.3.5. Infectious Diseases
12.3.6. Musculoskeletal Disorders
12.3.7. Orthopedics
12.3.8. Others (Genetic Disorders, etc.)
12.4. Market Value Forecast By End-user, 2020-2034
12.4.1. Hospitals
12.4.2. Specialty Clinics
12.4.3. Others
12.5. Market Value Forecast By Country/Sub-region, 2020-2034
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Therapy Type
12.6.2. By Indication
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Advanced Therapy Medicinal Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Therapy Type, 2020-2034
13.2.1. Cell Therapy
13.2.2. Gene Therapy
13.2.3. Tissue Engineering
13.3. Market Value Forecast By Indication, 2020-2034
13.3.1. Oncology
13.3.2. Neurology
13.3.3. Cardiology
13.3.4. Dermatology
13.3.5. Infectious Diseases
13.3.6. Musculoskeletal Disorders
13.3.7. Orthopedics
13.3.8. Others (Genetic Disorders, etc.)
13.4. Market Value Forecast By End-user, 2020-2034
13.4.1. Hospitals
13.4.2. Specialty Clinics
13.4.3. Others
13.5. Market Value Forecast By Country/Sub-region, 2020-2034
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Therapy Type
13.6.2. By Indication
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Advanced Therapy Medicinal Products Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Therapy Type, 2020-2034
14.2.1. Cell Therapy
14.2.2. Gene Therapy
14.2.3. Tissue Engineering
14.3. Market Value Forecast By Indication, 2020-2034
14.3.1. Oncology
14.3.2. Neurology
14.3.3. Cardiology
14.3.4. Dermatology
14.3.5. Infectious Diseases
14.3.6. Musculoskeletal Disorders
14.3.7. Orthopedics
14.3.8. Others (Genetic Disorders, etc.)
14.4. Market Value Forecast By End-user, 2020-2034
14.4.1. Hospitals
14.4.2. Specialty Clinics
14.4.3. Others
14.5. Market Value Forecast By Country/Sub-region, 2020-2034
14.5.1. GCC
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Therapy Type
14.6.2. By Indication
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2023)
15.3. Competitive Dashboard
15.3.1. By Region
15.3.2. By Therapy Type
15.4. Company Profiles
15.4.1. Spark Therapeutics, Inc.
15.4.1.1. Company Overview
15.4.1.2. Financial Overview
15.4.1.3. Product Portfolio
15.4.1.4. Business Strategies
15.4.1.5. Recent Developments
15.4.2. Bluebird Bio, Inc.
15.4.2.1. Company Overview
15.4.2.2. Financial Overview
15.4.2.3. Product Portfolio
15.4.2.4. Business Strategies
15.4.2.5. Recent Developments
15.4.3. Novartis AG.
15.4.3.1. Company Overview
15.4.3.2. Financial Overview
15.4.3.3. Product Portfolio
15.4.3.4. Business Strategies
15.4.3.5. Recent Developments
15.4.4. UniQure N.V.
15.4.4.1. Company Overview
15.4.4.2. Financial Overview
15.4.4.3. Product Portfolio
15.4.4.4. Business Strategies
15.4.4.5. Recent Developments
15.4.5. MEDIPOST
15.4.5.1. Company Overview
15.4.5.2. Financial Overview
15.4.5.3. Product Portfolio
15.4.5.4. Business Strategies
15.4.5.5. Recent Developments
15.4.6. Vericel Corporation
15.4.6.1. Company Overview
15.4.6.2. Financial Overview
15.4.6.3. Product Portfolio
15.4.6.4. Business Strategies
15.4.6.5. Recent Developments
15.4.7. PHARMICELL Co., Ltd
15.4.7.1. Company Overview
15.4.7.2. Financial Overview
15.4.7.3. Product Portfolio
15.4.7.4. Business Strategies
15.4.7.5. Recent Developments
15.4.8. Organogenesis Inc.
15.4.8.1. Company Overview
15.4.8.2. Financial Overview
15.4.8.3. Product Portfolio
15.4.8.4. Business Strategies
15.4.8.5. Recent Developments
15.4.9. Others Prominent Players
15.4.9.1. Company Overview
15.4.9.2. Financial Overview
15.4.9.3. Product Portfolio
15.4.9.4. Business Strategies
15.4.9.5. Recent Developments
List of Tables
Table 01: Global Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Therapy Type, 2020-2034
Table 02: Global Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 03: Global Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 04: North America Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Country, 2020-2034
Table 05: North America Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Therapy Type, 2020-2034
Table 06: North America Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 07: North America Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 08: Europe Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 09: Europe Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Therapy Type, 2020-2034
Table 11: Europe Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 12: Europe Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Therapy Type, 2020-2034
Table 15: Asia Pacific Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 16: Asia Pacific Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 17: Latin America Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Therapy Type, 2020-2034
Table 19: Latin America Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 20: Latin America Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Therapy Type, 2020-2034
Table 23: Middle East & Africa Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 24: Middle East & Africa Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast, 2020-2034
Figure 02: Global Advanced Therapy Medicinal Products Market Value Share, by Therapy Type, 2023
Figure 03: Global Advanced Therapy Medicinal Products Market Value Share, by Indication, 2023
Figure 04: Global Advanced Therapy Medicinal Products Market Value Share, by End-user, 2023
Figure 05: Global Advanced Therapy Medicinal Products Market Value Share, by Region, 2023
Figure 06: Global Advanced Therapy Medicinal Products Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
Figure 07: Global Advanced Therapy Medicinal Products Market Share Analysis, by Therapy Type, 2023
Figure 08: Global Advanced Therapy Medicinal Products Market Share Analysis, by Therapy Type, 2034
Figure 09: Global Advanced Therapy Medicinal Products Market Attractiveness Analysis, by Therapy Type, 2024-2034
Figure 10: Global Advanced Therapy Medicinal Products Market Value (US$ Mn), by Cell Therapy, 2020-2034
Figure 11: Global Advanced Therapy Medicinal Products Market Value Share Analysis, by Cell Therapy, 2023 and 2034
Figure 12: Global Advanced Therapy Medicinal Products Market Value (US$ Mn), by Gene Therapy, 2020-2034
Figure 13: Global Advanced Therapy Medicinal Products Market Value Share Analysis, by Gene Therapy, 2023 and 2034
Figure 14: Global Advanced Therapy Medicinal Products Market Value (US$ Mn), by Tissue Engineering, 2020-2034
Figure 15: Global Advanced Therapy Medicinal Products Market Value Share Analysis, by Tissue Engineering, 2023 and 2034
Figure 16: Global Advanced Therapy Medicinal Products Market Share Analysis, by Indication, 2023
Figure 17: Global Advanced Therapy Medicinal Products Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
Figure 18: Global Advanced Therapy Medicinal Products Market Share Analysis, by Indication, 2034
Figure 19: Global Advanced Therapy Medicinal Products Market Attractiveness Analysis, by Indication, 2024-2034
Figure 20: Global Advanced Therapy Medicinal Products Market Value (US$ Mn), by Oncology, 2020-2034
Figure 21: Global Advanced Therapy Medicinal Products Market Value Share Analysis, by Oncology, 2023 and 2034
Figure 22: Global Advanced Therapy Medicinal Products Market Value (US$ Mn), by Neurology, 2020-2034
Figure 23: Global Advanced Therapy Medicinal Products Market Value Share Analysis, by Neurology, 2023 and 2034
Figure 24: Global Advanced Therapy Medicinal Products Market Value (US$ Mn), by Cardiology, 2020-2034
Figure 25: Global Advanced Therapy Medicinal Products Market Value Share Analysis, by Cardiology, 2023 and 2034
Figure 26: Global Advanced Therapy Medicinal Products Market Value (US$ Mn), by Dermatology, 2020-2034
Figure 27: Global Advanced Therapy Medicinal Products Market Value Share Analysis, by Dermatology, 2023 and 2034
Figure 28: Global Advanced Therapy Medicinal Products Market Value (US$ Mn), by Infectious Diseases, 2020-2034
Figure 29: Global Advanced Therapy Medicinal Products Market Value Share Analysis, by Infectious Diseases, 2023 and 2034
Figure 30: Global Advanced Therapy Medicinal Products Market Value (US$ Mn), by Musculoskeletal Disorders, 2020-2034 Infectious Diseases
Figure 31: Global Advanced Therapy Medicinal Products Market Value Share Analysis, by Musculoskeletal Disorders, 2023 and 2034
Figure 32: Global Advanced Therapy Medicinal Products Market Value (US$ Mn), by Orthopedics, 2020-2034
Figure 33: Global Advanced Therapy Medicinal Products Market Value Share Analysis, by Orthopedics, 2023 and 2034
Figure 34: Global Advanced Therapy Medicinal Products Market Value (US$ Mn), by Others, 2020-2034
Figure 35: Global Advanced Therapy Medicinal Products Market Value Share Analysis, by Others, 2023 and 2034
Figure 36: Global Advanced Therapy Medicinal Products Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 37: Global Advanced Therapy Medicinal Products Market Share Analysis, by End-user, 2023
Figure 38: Global Advanced Therapy Medicinal Products Market Share Analysis, by End-user, 2034
Figure 39: Global Advanced Therapy Medicinal Products Market Attractiveness Analysis, by End-user, 2024-2034
Figure 40: Global Advanced Therapy Medicinal Products Market Value (US$ Mn), by Hospitals, 2020-2034
Figure 41: Global Advanced Therapy Medicinal Products Market Value Share Analysis, by Hospitals, 2023 and 2034
Figure 42: Global Advanced Therapy Medicinal Products Market Value (US$ Mn), by Specialty Clinics, 2020-2034
Figure 43: Global Advanced Therapy Medicinal Products Market Value Share Analysis, by Specialty Clinics, 2023 and 2034
Figure 44: Global Advanced Therapy Medicinal Products Market Value (US$ Mn), by Others, 2020-2034
Figure 45: Global Advanced Therapy Medicinal Products Market Value Share Analysis, by Others, 2023 and 2034
Figure 46: Global Advanced Therapy Medicinal Products Market Value Share Analysis, by Region, 2023 and 2034
Figure 47: Global Advanced Therapy Medicinal Products Market Share Analysis, by Region, 2023
Figure 48: Global Advanced Therapy Medicinal Products Market Share Analysis, by Region, 2034
Figure 49: Global Advanced Therapy Medicinal Products Market Attractiveness Analysis, by Region, 2023-2034
Figure 50: North America Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 51: North America Advanced Therapy Medicinal Products Market Value Share Analysis, by Country, 2023 and 2034
Figure 52: North America Advanced Therapy Medicinal Products Market Attractiveness Analysis, by Country, 2024-2034
Figure 53: North America Advanced Therapy Medicinal Products Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
Figure 54: North America Advanced Therapy Medicinal Products Market Share Analysis, by Therapy Type, 2023
Figure 55: North America Advanced Therapy Medicinal Products Market Share Analysis, by Therapy Type, 2034
Figure 56: North America Advanced Therapy Medicinal Products Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
Figure 57: North America Advanced Therapy Medicinal Products Market Share Analysis, by Indication, 2023
Figure 58: North America Advanced Therapy Medicinal Products Market Share Analysis, by Indication, 2034
Figure 59: North America Advanced Therapy Medicinal Products Market Value (US$ Mn) Share North America, by End-user, 2023 and 2034
Figure 60: North America Advanced Therapy Medicinal Products Market Share Analysis, by End-user, 2023
Figure 61: North America Advanced Therapy Medicinal Products Market Share Analysis, by End-user, 2034
Figure 62: Europe Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 63: Europe Advanced Therapy Medicinal Products Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 64: Europe Advanced Therapy Medicinal Products Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 65: Europe Advanced Therapy Medicinal Products Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
Figure 66: Europe Advanced Therapy Medicinal Products Market Share Analysis, by Therapy Type, 2023
Figure 67: Europe Advanced Therapy Medicinal Products Market Share Analysis, by Therapy Type, 2034
Figure 68: Europe Advanced Therapy Medicinal Products Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
Figure 69: Europe Advanced Therapy Medicinal Products Market Share Analysis, by Indication, 2023
Figure 70: Europe Advanced Therapy Medicinal Products Market Share Analysis, by Indication, 2034
Figure 71: Europe Advanced Therapy Medicinal Products Market Value (US$ Mn) Share North America, by End-user, 2023 and 2034
Figure 72: Europe Advanced Therapy Medicinal Products Market Share Analysis, by End-user, 2023
Figure 73: Europe Advanced Therapy Medicinal Products Market Share Analysis, by End-user, 2034
Figure 74: Asia Pacific Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 75: Asia Pacific Advanced Therapy Medicinal Products Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 76: Asia Pacific Advanced Therapy Medicinal Products Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 77: Asia Pacific Advanced Therapy Medicinal Products Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
Figure 78: Asia Pacific Advanced Therapy Medicinal Products Market Share Analysis, by Therapy Type, 2023
Figure 79: Asia Pacific Advanced Therapy Medicinal Products Market Share Analysis, by Therapy Type, 2034
Figure 80: Asia Pacific Advanced Therapy Medicinal Products Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
Figure 81: Asia Pacific Advanced Therapy Medicinal Products Market Share Analysis, by Indication, 2023
Figure 82: Asia Pacific Advanced Therapy Medicinal Products Market Share Analysis, by Indication, 2034
Figure 83: Asia Pacific Advanced Therapy Medicinal Products Market Value (US$ Mn) Share North America, by End-user, 2023 and 2034
Figure 84: Asia Pacific Advanced Therapy Medicinal Products Market Share Analysis, by End-user, 2023
Figure 85: Asia Pacific Advanced Therapy Medicinal Products Market Share Analysis, by End-user, 2034
Figure 86: Latin America Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 87: Latin America Advanced Therapy Medicinal Products Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 88: Latin America Advanced Therapy Medicinal Products Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 89: Latin America Advanced Therapy Medicinal Products Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
Figure 90: Latin America Advanced Therapy Medicinal Products Market Share Analysis, by Therapy Type, 2023
Figure 91: Latin America Advanced Therapy Medicinal Products Market Share Analysis, by Therapy Type, 2034
Figure 92: Latin America Advanced Therapy Medicinal Products Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
Figure 93: Latin America Advanced Therapy Medicinal Products Market Share Analysis, by Indication, 2023
Figure 94: Latin America Advanced Therapy Medicinal Products Market Share Analysis, by Indication, 2034
Figure 95: Latin America Advanced Therapy Medicinal Products Market Value (US$ Mn) Share North America, by End-user, 2023 and 2034
Figure 96: Latin America Advanced Therapy Medicinal Products Market Share Analysis, by End-user, 2023
Figure 97: Latin America Advanced Therapy Medicinal Products Market Share Analysis, by End-user, 2034
Figure 98: Middle East & Africa Advanced Therapy Medicinal Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 99: Middle East & Africa Advanced Therapy Medicinal Products Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 100: Middle East & Africa Advanced Therapy Medicinal Products Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 101: Middle East & Africa Advanced Therapy Medicinal Products Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
Figure 102: Middle East & Africa Advanced Therapy Medicinal Products Market Share Analysis, by Therapy Type, 2023
Figure 103: Middle East & Africa Advanced Therapy Medicinal Products Market Share Analysis, by Therapy Type, 2034
Figure 104: Middle East & Africa Advanced Therapy Medicinal Products Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
Figure 105: Middle East & Africa Advanced Therapy Medicinal Products Market Share Analysis, by Indication, 2023
Figure 106: Middle East & Africa Advanced Therapy Medicinal Products Market Share Analysis, by Indication, 2034
Figure 107: Middle East & Africa Advanced Therapy Medicinal Products Market Value (US$ Mn), by End-user, 2023 and 2034
Figure 108: Middle East & Africa Advanced Therapy Medicinal Products Market Share Analysis, by End-user, 2023
Figure 109: Middle East & Africa Advanced Therapy Medicinal Products Market Share Analysis, by End-user, 2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Advanced Therapy Medicinal Products Market
